Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Revenue

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Net Sales ₹8,749 Cr₹7,782 Cr₹6,214 Cr₹5,872 Cr₹4,980 Cr

What is the latest Revenue of MANKIND PHARMA ?

The latest Revenue ratio of MANKIND PHARMA is ₹8,749 Cr based on Mar2023 Consolidated results.
Year Revenue
Mar2023₹8,749 Cr
Mar2022₹7,782 Cr
Mar2021₹6,214 Cr
Mar2020₹5,872 Cr
Mar2019₹4,980 Cr

How is Revenue of MANKIND PHARMA Trending?

Years Revenue % Change
Mar2023 ₹8,749 Cr
12.44
Mar2022 ₹7,782 Cr
25.22
Mar2021 ₹6,214 Cr
5.83
Mar2020 ₹5,872 Cr
17.91
Mar2019 ₹4,980 Cr -

Compare Revenue of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹85,970.8 Cr 1.5% -8.1% 53.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹350,339.0 Cr -0.5% -3.8% 50.8% Stock Analytics
CIPLA ₹116,930.0 Cr -2% 2% 53.3% Stock Analytics
DIVIS LABORATORIES ₹114,416.0 Cr 1.3% 8.7% 26.8% Stock Analytics
ZYDUS LIFESCIENCES ₹100,694.0 Cr -5.5% 1.3% 99.9% Stock Analytics
DR REDDYS LABORATORIES ₹96,546.9 Cr -1.7% -8% 28.9% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.5%

-8.1%

53.1%

SENSEX

-1.9%

-0.7%

18.3%


You may also like the below Video Courses